Clinical Colorectal Cancer
Издатель: Elsevier · ISSN 1533-0028 · 44 статей
- Comparing Quality of Life in Rectal Cancer Survivors Managed With Watch-and-Wait Versus Surgery
- Prognostic Value of Liver Metastases and KRAS Mutations in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Third-Line Placebo-Controlled Trials From the ARCAD CRC Database
- The Impact of Lesion Morphology and Resection Strategy on Curative Outcomes in Colorectal Malignant Polyps
- Neoadjuvant Bevacizumab and Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-Term Outcomes of a Multicentre Study
- Colorectal Cancer Screening at Younger Ages: A Multicutoff Analysis of FIT Performance
- Application of a Domestic Chinese Robotic Surgical System in Radical Resection Combined With Lateral Lymph Node Dissection for Low Rectal Cancer: A Retrospective Study
- A Phase I Study of Nab-Paclitaxel, Gemcitabine and AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas: ECOG-ACRIN EA2131
- Population-Based Multicenter Real-World Outcomes of Encorafenib Plus Panitumumab in BRAF V600E-Mutated Metastatic Colorectal Cancer
- Diagnostic and Treatment Intervals for Colorectal Cancer and Associations With Overall Survival and Disease Stage: An Australian Data Linkage Study
- EGFR Targeting With Afatinib and Cetuximab Versus Cetuximab Alone in Chemorefractory Wild-type RAS Metastatic Colorectal Cancer: A Randomized Phase II Study With Circulating Tumor Cell Analysis
- Liver Transplantation for Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis of Survival Outcomes
- Real-World Treatment and Outcomes for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer Following Pembrolizumab Availability in Australia
- Early-Onset Colorectal Cancer: Epidemiology, Etiologic Pathways, and Emerging Prevention Strategies
- Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab as Third-Line Treatment in Circulating Tumor DNA–Selected Metastatic Colorectal Cancer (ROMANCE Trial)